Details for New Drug Application (NDA): 215334
✉ Email this page to a colleague
The generic ingredient in PLERIXAFOR is plerixafor. There are seven drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the plerixafor profile page.
Summary for 215334
Tradename: | PLERIXAFOR |
Applicant: | Amneal |
Ingredient: | plerixafor |
Patents: | 0 |
Pharmacology for NDA: 215334
Physiological Effect | Increased Hematopoietic Stem Cell Mobilization |
Suppliers and Packaging for NDA: 215334
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
PLERIXAFOR | plerixafor | SOLUTION;SUBCUTANEOUS | 215334 | ANDA | Amneal Pharmaceuticals LLC | 70121-1694 | 70121-1694-2 | 1 VIAL, SINGLE-DOSE in 1 CARTON (70121-1694-2) / 1.2 mL in 1 VIAL, SINGLE-DOSE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;SUBCUTANEOUS | Strength | 24MG/1.2ML (20MG/ML) | ||||
Approval Date: | Jul 24, 2023 | TE: | AP | RLD: | No |
Complete Access Available with Subscription